It is well known that HIV increases the risk for lung cancer, and because more than 40% of the HIV population in the United States are smokers, researchers aimed to better understand the mortality rate...
Evidence linking supplemental vitamin B use and lung cancer has been inconsistent. In a recent study, researchers sought to investigate this association among individuals who reported long-term use of...
In a recent study, researchers compared the safety, efficacy, and tolerability of 2 treatment combinations for patients with non-small cell lung cancer with brain metastases. To see results of the study,...
A recent study assessed the efficacy of atezolizumab across different lines of therapy in patients with advanced non-small cell lung cancer. For study results, including the objective response rate after 12...
The US Food and Drug Administration has approved the first treatment for a genetic mutation of non-small cell lung cancer, and also approved the diagnostic test for determining multiple genetic mutations...
The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.
